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1 Current address: INSERM U845, Paris 75015, FrancCoenzyme A synthase (CoAsy) is a bifunctional enzyme which facilitates the last two steps of Coen-
zyme A biogenesis in higher eukaryotes. Here we describe that CoAsy forms a complex with enhan-
cer of mRNA-decapping protein 4 (EDC4), a central scaffold component of processing bodies. CoAsy/
EDC4 complex formation is regulated by growth factors and is affected by cellular stresses. EDC4
strongly inhibits the dephospho-CoA kinase activity of CoAsy in vitro. Transient overexpression of
EDC4 decreases cell proliferation, and further co-expression of CoAsy diminishes this effect. Here
we report that EDC4 might contribute to regulation of CoA biosynthesis in addition to its scaffold
function in processing bodies.
Structured summary of protein interactions:
CoAsy physically interacts with EDC4 by anti bait coimmunoprecipitation (View Interaction: 1, 2, 3)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
CoA is essential for diverse biochemical processes in all cells
and functions as an obligate cofactor for over 4% of cellular en-
zymes [1]. CoA is implicated in citric acid cycle, biosynthesis and
beta-oxidation of fatty acids, ketone bodies and cholesterol metab-
olism. Furthermore, CoA and its derivatives (acetyl-CoA and malo-
nyl-CoA) are actively involved in the regulation of membrane
trafﬁcking, signal transduction and gene expression [2–4].
The level of CoA is not steady-state in cells and changes in re-
sponse to various extracellular stimuli, namely hormones, nutri-
ents and cellular metabolites [5,6]. The biosynthesis of CoA
involves ﬁve enzymatic steps which are universal among prokary-
otes and eukaryotes. To date, all enzymes implicated in the biogen-
esis of CoA have been identiﬁed and characterized. CoA synthase
(CoAsy) catalyzes the last two steps in CoA biosynthesis in higher
eukaryotes [7]. CoAsy has two enzymatic activities: 40-phospho-
pantethein adenylyltransferase (PPAT) and dephospho-CoA kinase
(dPCoAK). We have demonstrated that N-terminal sequence of 29
amino acids is responsible for targeting CoAsy to the mitochondrial
outer membrane (MOM) [8]. The main components of MOM (phos-chemical Societies. Published by E
va).
e.phatidylcholine and phosphatidylethanolamine) strongly activate
both catalytic activities of CoAsy [8]. Exploring CoAsy interaction
network we found and characterized a number of complexes
including CoAsy and S6K1, p85a regulatory subunit of PI3K,
Shp2PTP [9–11], implying that diverse signaling pathways may
play a role in the regulation of CoA biosynthesis.
In this study, we describe CoAsy as a novel binding partner of
enhancer of mRNA-decapping protein 4 (EDC4), the scaffold pro-
tein of processing bodies (P-bodies, PBs) [12–14]. In Homo sapiens,
Drosophila melanogaster and Arabidopsis thaliana EDC4 is required
for PBs’ integrity and promotes a physical bridge between decap-
ping enzyme and its co-activator – DCP2 and DCP1, respectively
[15,16]. The full-length EDC4 protein represents a 1401 amino
acids polypeptide and contains seven WD40 repeats at the N-ter-
minal part, which are organized in seven-bladed beta-propeller
fold [12,16]. Such module is a very common for scaffold proteins
and mediates the protein–protein interactions [17]. C-terminal do-
main of EDC4 contains an alfa helical fold, highly conserved across
species and is necessary for PBs targeting and homodimer forma-
tion [12,16]. The N- and C-terminal globular domains are linked
by low-complexity serine-rich region and nuclear localization se-
quence [16,18].
Here we demonstrate that CoAsy/EDC4 complex exists under
physiological conditions, is regulated by growth factors and is af-
fected by osmotic and oxidative stresses. Furthermore, we showlsevier B.V. All rights reserved.
D. Gudkova et al. / FEBS Letters 586 (2012) 3590–3595 3591the mitochondrial localization of EDC4 under physiological condi-
tions and its alteration under stress conditions. Additionally, we
provide the evidence about an inhibition of CoAsy activity by
EDC4, which results in the inhibition of cell proliferation. In sum,
we report a non-canonical function of EDC4, a scaffold protein of
PBs in regulation of CoA biogenesis in human cells.
2. Materials and methods
2.1. Cell culture and reagents
HEK293 cell line was obtained from the American Type Culture
Collection and insect Sf9 cell line was purchased from Invitrogen.
The cells were maintained in DMEM or Lonza Xpress medium
respectively, supplemented with 10% fetal bovine serum (Hy-
Clone), penicillin (200 U/ml) and streptomycin (200 mg/ml). For
the induction of stress response, cells were treated with H2O2 (10
and 100 lM), sorbitol (0.5 M) and rotenone (50 lM) for 30 min.
All reagents were obtained from Sigma. Transfection of cells was
carried out using JetPEI transfection reagent (PolyPlus) as recom-
mended by the manufacturer. Generation of stable cell lines over-
expressing CoAsy and GFP was previously described [19].
2.2. Antibodies and plasmids
The production of rabbit a-CoAsy and mouse a-EDC4 antibodies
was described previously [7,20]. a-HA and a-actin antibodies were
obtained from Sigma. Rabbit polyclonal a-EDC4 antibody was from
Bethyl Laboratories (commercial name is anti-RCD-8 antibody). a-
VDAC antibody was from Cell Signalling. Variants of EDC4 (Uni-
ProtKB reference number Q6P2E9) – EDC4wt, EDC41–500, EDC41–
914 were ampliﬁed by PCR and cloned into pcDNA4/TO vector
(Invitrogen) in frame with N-terminal HA-tag. EDC4wt and
EDC41–500 mutant were cloned into pFAST Bac-HTA vector (Invitro-
gen) in frame with the N-terminal His-HA-tag.
2.3. Production and afﬁnity puriﬁcation of recombinant proteins
Generation of recombinant baculoviruses was carried using
Bac-to-Bac expression system (Invitrogen). Ampliﬁcation of re-
combinant baculoviruses, infection of Sf9 cells and afﬁnity puriﬁ-
cation of His-HA-EDC4wt and His-HA-EDC41–500 proteins were
performed following manufacturer’s recommendations. Expression
and puriﬁcation of CoAsy-His and His-dpCoAk proteins were de-
scribed previously [7].
2.4. Immunoprecipitation (IP) and immunoblotting (IB)
Immunoprecipitation (IP) and immunoblotting (IB) were per-
formed as described previously [10,20]. As a control of non-speciﬁc
binding appropriate amount of rabbit a-GFP serum was used. Gel
was silver stained with Silver Stain Kit (Pierce).
2.5. Subcellular fractionation
Mitochondria isolation from HEK293 cells was performed as de-
scribed [21]. VDAC protein was used as a quality control of puriﬁed
fractions.
2.6. Analysis of dephospho-CoA kinase activity of CoAsy
Analysis of dephospho-CoA kinase activity of CoAsy was as-
sayed as described in [7] by a luciferase test and thin layer chroma-
tography (TLC). Brieﬂy, CoAsy or dPCoAk were added at 240 nM
concentrations and then further serially diluted to the ﬁnalconcentration 9 nM. Amount of EDC4wt per each reaction was con-
stant (16 nM). After 30 min of incubation at 25 C reactions were
stopped by adding 1 mM EDTA. BGG was from Fermentas. Level
of unincorporated ATP was measured by Kinase-Glo Luminescent
Kinase assay (Promega) using Mithras LB940 (Berthold Technolo-
gies). In case of TLC assay 2.5 lCi of [c-33P] ATP was added to reac-
tion mixture. In these experiments the amounts of EDC4wt or
EDC41–500 was decreasing in series from 16 to 0.15 nM, while
CoAsy concentration remained constant (240 nM). A phosphorim-
ager system (Bio-Rad) was used to identify the position of resolved
radiolabelled products. The assay was reproduced in four indepen-
dent experiments.
2.7. Total CoA measurement
Total CoA measurement was assayed in 3 days posttransfection
cells as described in [22] with use of a C18 column (00A-4462-E0,
Phenomenex). CoA was detected at an absorbance of 254 nm. Data
are representative of three independent experiments.
2.8. Cell proliferation assay
Parental HEK293 cells were seeded in 6-well plates (20–
25  103/well). Twenty four hours after transfection, cells were
counted over the next three subsequent days using Cell Counter
Analyzer. HEK293 cells stably expressing CoAsy-Myc or GFP were
seeded into four separate 96-well plates in four repeats
(1000 cells/well). Twenty four hours posttransfection cell prolifer-
ation rate was measured by MTT assay over the next three days as
recommended by manufacturer. Growth curve for each case is pre-
sented as the mean ± SD and represents data from four indepen-
dent experiments.
3. Results
3.1. Identiﬁcation of EDC4 as CoAsy binding partner in HEK293 cells
To identify novel binding partners of CoAsy we employed an
immunoprecipitation assay (Fig. 1A). Proteins co-puriﬁed with
CoAsy were resolved in SDS–PAGE, silver stained and subjected
to analysis by mass spectrometry. One of the several iden-
tiﬁed partners was EDC4 (also known as Ge-1, Hedls, RCD-8)
[12–15,23,24]. To verify the data of mass spectrometry imunopre-
cipitated CoAsy complexes were analyzed by immunoblotting
using a-EDC4 and a-CoAsy antibodies. As Fig. 1B shows, endoge-
nous EDC4 formed a complex with CoAsy in HEK293 cells.
3.2. CoAsy/EDC4 complex stability depends on growth factors and
cellular stresses
We have recently reported that CoAsy could form complexes
with proteins which are part of signal transduction network
[9,10]. Here we asked whether the formation of complex between
EDC4 and CoAsy could be regulated in a growth factor dependent
manner. As shown on Fig. 1C the efﬁciency of complex formation
between CoAsy and EDC4 depends on mitogens stimulation. In
growing cells interaction between CoAsy and EDC4 was readily
detected, but under starvation the efﬁciency of CoAsy/EDC4 associ-
ation was signiﬁcantly reduced in time-dependent manner. The re-
stimulation of starved HEK293 cells restored CoAsy/EDC4 complex.
The level of PBs’ assembly reﬂects a translational state of mRNA
within cells and a variety of stress conditions (metabolic stresses,
production of ROS, alterations in biosynthetic processes) affect
PBs’ formation [13,23–25]. Keeping this in mind we decided to test
the interaction between CoAsy and EDC4 under various
Fig. 1. CoAsy forms a complex with EDC4. (A and B) EDC4 interacts with CoAsy in growing HEK293 cells. CoAsy protein complexes were resolved in SDS–PAGE, silver stained
(A) and speciﬁc bands were analyzed by mass spectrometry. (B) Immunoblot of CoAsy immunoprecipitates with antibodies against EDC4 and CoAsy. (C) CoAsy/EDC4 complex
formation depends on growth factors availability. Cells were cultured in serum-free medium for 12 or 24 h and then treated without or with 10% FBS for 0.5 or 3 h. Cell lysates
were applied for IP with a-CoAsy antibodies with further analysis by IB. (D) EDC4 interacts with CoAsy under physiological conditions. Cells were treated with H2O2, rotenone
and sorbitol in indicated concentrations for 0.5 h. Cleared lysates were used for IP with a-CoAsy antibodies. Complexes were analyzed by IB using indicated antibodies. (E)
EDC4 distributed on mitochondria and cytosol. HEK293 cells after UV (50 J/m2) and oxidative (H2O2 in indicated concentration) stressing during 0.5 h were fractionated into
cytosolic and mitochondrial fractions. Fractions were analyzed by IB using a-EDC4 antibodies. Purity of obtained fractions was veriﬁed with a-VDAC antibodies.
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sorbitol and rotenone for the induction of an oxidative, osmotic
and mitochondrial stresses, respectively. As Fig. 1D shows the os-
motic and oxidative stresses strongly inhibited the interaction be-
tween CoAsy and EDC4, while blocking of mitochondrial
respiration by rotenone had no effect on the complex formation.
3.3. EDC4 is distributed within the cytosol and mitochondria under
physiological conditions
Based on our previous observation of CoAsy localization on
mitochondrial outer membrane [8] we speculated that EDC4 as
its binding partner could localize there as well. To test this hypoth-
esis we have puriﬁedmitochondria from growing HEK293 cells and
analyzed obtained fractions by immunoblot with antibodies
against EDC4 and CoAsy. We have found EDC4 within the cytosol
as well as in mitochondria fraction (Fig. 1E). As CoAsy/EDC4 com-
plex formation is altered by osmotic and oxidative stresses
(Fig. 1D) we studied whether subcellular distribution of EDC4 is af-
fected by these conditions. Indeed, oxidative stress led to decreas-
ing of EDC4 amount in mitochondria fraction (Fig. 1E).
3.4. Native EDC4wt inhibits the dephospho-CoA kinase activity of
CoAsy in vitro
Next, we have asked whether EDC4 affects enzymatic activity of
CoAsy. To test it we have employed an in vitro kinase assay with
baculovirally expressed CoAsy and EDC4wt (SupplementaryFig. 1). As readout of dephospho-CoA kinase activity of CoAsy, we
measured changes in ATP level, which is used for generation of
CoA from dephospho-CoA. Fig. 2A demonstrates that EDC4wt
strongly inhibited CoAsy activity in a concentration-dependent
manner. The activity of separate dPCoAk domain of CoAsy was also
abolished by EDC4wt. In addition, we conﬁrmed the inhibitory ef-
fect of EDC4wt by direct detection of 33P-labeled CoA production
that was monitored by a thin layer chromatography. Next, we
tested the effect of truncated mutant of EDC4 on CoAsy dephos-
pho-CoA kinase activity. Consistent with the observation that
EDC41–500 does not bind CoAsy (Supplementary Fig. 2) EDC41-500
had no effect on CoAsy activity in contrast to the native EDC4wt
(Fig. 2B). Furthermore, heat denaturation of EDC4wt abolished its
effects on CoAsy activity (Fig. 2C).
3.5. EDC4 negatively affects cell proliferation which could be rescued
by CoAsy overexpression
The observation that CoAsy activity is inhibited by EDC4 in vitro
led us to hypothesize that overexpression of EDC4 in mammalian
cells might have an impact on cellular growth and metabolism. In-
deed, transient overexpression of full-length EDC4wt caused the
inhibition of HEK293 cell proliferation (Fig. 3A, Supplementary
Fig. 3), in contrast to EDC41–500 mutant, which does not interact
with CoAsy (Supplementary Fig. 2) and in addition does not colo-
calized with P-bodies (data not shown). Furthermore, we show
that transient expression of EDC4wt led to 40% decrease of total
CoA level in cells (Fig. 3B) while expression level of endogenous
Fig. 2. Native EDC4wt affects CoAsy activity. (A) EDC4wt inhibits dephosho-CoA kinase activity of CoAsy, which was assayed by luciferase test as described under Materials
and Methods. Curve represents a relative dPCoA kinase activity ratio to control (CoAsywt by itself) BGG, a bovine gamma-globulin, was used as a control. Amount of EDC4 or
BGG was 16 nM in every sample. (B) EDC41–500 mutant does not affect CoAsy activity. The reaction was assayed by TLC as described under Materials and Methods. Positions of
33P-labeled CoA and ATP are indicated by arrows. (C) Native folding of EDC4wt is required for the inhibition of CoAsy activity. EDC4wt was heat denaturated at 95 C for 10 min
and then used in experiment in parallel with untreated EDC4wt. Detection of CoA was performed as described in (B).
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bly expressing CoAsy were found to be partially resistant to the
inhibitory effects of EDC4wt overexpression as their proliferation
was partially rescued compared to the control cells stably express-
ing GFP (Fig. 3D, Supplementary Fig. 4). Similar effect was observed
in HEK293 cells, transiently co-expressing CoAsy and EDC4wt (data
not shown).
4. Discussion
Pantothenate kinase (PanK) was established as a primary rate-
limiting enzyme in biosynthesis of CoA in cells, representing a sin-
gle regulatory point of this pathway [6]. More recent discovery andbiochemical characterization of CoAsy had improved signiﬁcantly
our present knowledge about CoA biogenesis and CoAsy was
proposed as a second rate-limiting enzyme in that process
[7,8,11]. So far a number of CoAsy binding proteins including ki-
nases and phosphatase (e.g., p85a subunit of PI3K, S6K1, Shp2PTP)
were identiﬁed. These data allow us to speculate about involve-
ment of signaling pathways in regulation of CoA biogenesis to-
gether with regulation of PanK activity [9–11]. However, to date
the precise mechanisms of these regulations remain poorly
understood.
Here we report and characterize EDC4 as novel binding partner
of CoAsy. EDC4 is best known for its crucial role for PBs assembly.
Identiﬁcation of protein involved in degradation and storing of
Fig. 3. Overexpression of EDC4wt affects cell proliferation (A) and results in decrease of total intracellular CoA level (B), despite the steady-state CoAsy level in cells (C). Total
CoA was measured 72 h posttransfection and compared to CoA level in HEK293 cells, transfected with vector. The graph displays a relative CoA level towards to a control,
taken as 100%. (D) Stable expression of CoAsy diminished a negative effect of EDC4wt overexpression. Cells, stably expressing CoAsy-Myc or GFP (control) were transiently
transfected with pcDNA4/TO-EDC4wt or pcDNA4/TO plasmid DNA constructs. Level of proliferation was assayed using MTT test over the next three days. The data are the
mean of four independent experiments ± S.D.
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with CoAsy prompted us to speculate about novel mechanisms of
CoA biogenesis regulation. Since CoAsy was found on mitochondria
[8] we supposed that CoAsy may recruit EDC4 to mitochondria and
serve as its repository there. Indeed, we demonstrated the
existence of a mitochondrial pool of EDC4 under physiological con-
ditions that was affected by osmotic and oxidative stresses. Inter-
estingly, no mitochondrial localization signals had been predictedin EDC4 structure. We propose that cytosolic pool of EDC4 is deter-
mined by its function in PBs’ organization, while the signiﬁcance of
mitochondrial pool has to be deﬁned. Probably, mitochondria
could represent the intracellular sites, where a sequestered from
organization of PBs’ pool of EDC4 can be stored under physiological
conditions and further used for rapid PBs’ assembly after stress
induction. The following characterization of CoAsy/EDC4 complex
has revealed that it is affected by osmotic and oxidative stresses,
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different mechanisms of the induction of cellular stresses as well
as their consequences. It is known, that osmotic and oxidative
stresses in short time upon induction lead to abolishing of all bio-
synthetic processes and result in increase of PBs’ number (for deg-
radation of damaged mRNAs) and appearance of stress granules
(for temporal storage of non-translating mRNAs pool)
[12,13,23,24]. At the same time treatment with rotenone leads to
the inhibition of respiratory chain in mitochondria with no direct
effect on proteins and/or mRNA’s metabolism, and no effect on
number/size of PBs in cell. Moreover, recently it was shown, that
treatment of cells with other mitochondrial uncoupler CCCP had
no effect on PBs number or size [25].
Exploration of functional link between CoAsy and EDC4 re-
vealed an inhibition of dephospho-CoA kinase activity of CoAsy
by EDC4 in vitro. Our results suggest that inhibition of CoAsy oc-
curs in non-equimolar ratio as the concentration of EDC4 was
about 14-times less than the CoAsy concentration. This observation
remains unexplained and is a subject for future studies. Our data
point to the importance of the correctly folded EDC4wt protein
for the inhibition of CoAsy. Moreover, in line with our in vitro ﬁnd-
ings we provide the evidence that transient overexpression of
EDC4 had a negative impact on cell proliferation. Interestingly,
our attempts to generate cell lines stably expressing EDC4wt were
not successful. We cannot exclude that it may be caused by in-
creased level of PBs and subsequent increased level of mRNA deg-
radation in cells. Other explanation could be that overexpression of
EDC4 results in the inhibition of CoA biosynthesis below tolerable
level. Observed decrease of total CoA level in such cells supports
this hypothesis. Also we have demonstrated that co-expression of
CoAsy and EDC4 could partially rescue cell proliferation. We pro-
posed that overexpression of EDC4 leads to a change of intracellu-
lar balance between CoAsy and EDC4 proteins engaged in complex
formation. Thereby, inhibition of CoAsy activity by EDC4 results in
decrease of CoA level which is necessary for energy metabolism
and suppresses cell proliferation in turn. Thus, increasing protein
level of CoAsy in cells overexpressing EDC4 could shift the ratio be-
tween elevated level of EDC4 and endogenous CoAsy to physiolog-
ically relevant balance.
In brief, we propose that a scaffold protein of PBs could be a no-
vel regulator of CoAsy activity and may contribute to the regula-
tion of total CoA level in cells. We provide the evidence of the
rate-limiting enzyme in CoA biosynthesis pathway regulation by
protein, which is not involved in energetic metabolism. However,
a plethora of questions about precise molecular mechanisms, con-
tribution of signaling pathways as well as a physiological relevance
remains to be addressed.
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